Does CAPMATINIB Cause Joint swelling? 92 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Joint swelling have been filed in association with CAPMATINIB (TABRECTA). This represents 4.0% of all adverse event reports for CAPMATINIB.
92
Reports of Joint swelling with CAPMATINIB
4.0%
of all CAPMATINIB reports
1
Deaths
8
Hospitalizations
How Dangerous Is Joint swelling From CAPMATINIB?
Of the 92 reports, 1 (1.1%) resulted in death, 8 (8.7%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Joint swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPMATINIB. However, 92 reports have been filed with the FAERS database.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Joint swelling?
ETANERCEPT (18,462)
ABATACEPT (18,453)
ADALIMUMAB (18,266)
METHOTREXATE (17,657)
TOCILIZUMAB (14,831)
LEFLUNOMIDE (13,026)
HYDROXYCHLOROQUINE (11,353)
RITUXIMAB (11,170)
TOFACITINIB (10,686)
INFLIXIMAB (9,853)
Which CAPMATINIB Alternatives Have Lower Joint swelling Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN